Actos, the Highest Grossing Diabetes Drug, Causes Bladder Cancer?
By Scott Hardy
Actos (pioglitazone) continued to be a strong performer for Takeda Pharmaceuticals in 2011 bringing in billions of dollars to the drug giant. Lawsuits alleging that Actos causes bladder cancer started hitting the courts last year which may have been a factor in causing Actos to drop from $3.5 billion in sales in 2010 to $3.4 billion in 2011 (according to IMS Health.) As more consumers are alerted to the possible danger of taking Actos many may have decided to switch to a different treatment option for their Type-2 Diabetes.
Updated April 24th, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement